Screener
Travere Therapeutics, Inc. TVTX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed October 31, 2024. Open the filing →
- Filed
- Oct 31, 2024
- Fiscal quarter
- Q3 FY2024
- Calendar quarter
- Q3 2024
- Accession
- 0001438533-24-000048
FAQ
- What is Travere Therapeutics, Inc.'s free cash flow margin?
- Travere Therapeutics, Inc. (TVTX) reported free cash flow margin of -133.9% in Q3 2024.
- How has Travere Therapeutics, Inc.'s free cash flow margin changed year-over-year?
- Travere Therapeutics, Inc.'s free cash flow margin increased by 34.5% year-over-year, from -204.5% to -133.9%.
- What is the long-term trend for Travere Therapeutics, Inc.'s free cash flow margin?
- Over 2 years (2020 to 2023), Travere Therapeutics, Inc.'s free cash flow margin has grown at a 166.8% compound annual growth rate (CAGR), from -27.1% to -193.3%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Travere Therapeutics, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude